This bill amends RSA 318-B:9 to allow pharmacists to not only sell and dispense controlled drugs but also to administer certain long-acting controlled drugs pursuant to a prescription. The new legal language includes the insertion of "and administer" in multiple sections, indicating that pharmacists are now authorized to administer these drugs in addition to their existing roles. Additionally, the bill specifies that pharmacists who administer drugs will be reimbursed for these administration services, which is a new provision aimed at ensuring that pharmacists are compensated for their expanded responsibilities.

The bill also includes several deletions, such as the removal of "and" in various instances, which streamlines the language of the law. Other provisions remain intact, including the requirements for prescriptions and the stipulations regarding the sale and dispensing of controlled drugs. The act is set to take effect 60 days after its passage, with an effective date of August 23, 2025.

Statutes affected:
Introduced: 318-B:9
As Amended by the Senate: 318-B:9
Version adopted by both bodies: 318-B:9
CHAPTERED FINAL VERSION: 318-B:9